Stay updated on Upadacitinib in RA: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.

Latest updates to the Upadacitinib in RA: Safety & Efficacy Clinical Trial page
- Check2 days agoChange DetectedNo significant changes were detected in the BALANCE-EXTEND study page. The content and structure appear the same across screenshots.SummaryDifference0.2%

- Check9 days agoNo Change Detected
- Check23 days agoChange DetectedRemoved a MedlinePlus Genetics topic on Rheumatoid arthritis from the page.SummaryDifference0.1%

- Check30 days agoChange Detected- Updated revision from v3.1.0 to v3.2.0 and added a government funding notice and operating status guidance; added MedlinePlus Genetics topic on Rheumatoid arthritis; removed prior v3.1.0 reference.SummaryDifference1%

- Check38 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.0%

- Check52 days agoChange DetectedLocation labels updated to use the local term 'Respublika' and the version bumped to v3.0.2; a minor UI element ('Back to Top') was removed.SummaryDifference0.2%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib in RA: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in RA: Safety & Efficacy Clinical Trial page.